126 related articles for article (PubMed ID: 38613217)
21. Transforming growth factor-β1-overexpressing mesenchymal stromal cells induced local tolerance in rat renal ischemia/reperfusion injury.
Cai J; Jiao X; Zhao S; Liang Y; Ning Y; Shi Y; Fang Y; Ding X; Yu X
Cytotherapy; 2019 May; 21(5):535-545. PubMed ID: 30685215
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal Stromal Cells Inhibit Aerobic Glycolysis in Activated T Cells by Negatively Regulating Hexokinase II Activity Through PD-1/PD-L1 Interaction.
Kawasaki Y; Sato K; Mashima K; Nakano H; Ikeda T; Umino K; Morita K; Izawa J; Takayama N; Hayakawa H; Tominaga K; Endo H; Kanda Y
Transplant Cell Ther; 2021 Mar; 27(3):231.e1-231.e8. PubMed ID: 35348117
[TBL] [Abstract][Full Text] [Related]
23. Lactate induced mesenchymal stem cells activation promotes gastric cancer cells migration and proliferation.
Tao Z; Huang C; Wang D; Wang Q; Gao Q; Zhang H; Zhao Y; Wang M; Xu J; Shen B; Zhou C; Zhu W
Exp Cell Res; 2023 Mar; 424(1):113492. PubMed ID: 36702194
[TBL] [Abstract][Full Text] [Related]
24. Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.
Kim JY; Park M; Kim YH; Ryu KH; Lee KH; Cho KA; Woo SY
J Tissue Eng Regen Med; 2018 Feb; 12(2):e1022-e1033. PubMed ID: 28107610
[TBL] [Abstract][Full Text] [Related]
25. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
Kawada-Horitani E; Kita S; Okita T; Nakamura Y; Nishida H; Honma Y; Fukuda S; Tsugawa-Shimizu Y; Kozawa J; Sakaue T; Kawachi Y; Fujishima Y; Nishizawa H; Azuma M; Maeda N; Shimomura I
Diabetologia; 2022 Jul; 65(7):1185-1197. PubMed ID: 35511238
[TBL] [Abstract][Full Text] [Related]
26. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
[TBL] [Abstract][Full Text] [Related]
27. Small extracellular vesicles derived from PD-L1-modified mesenchymal stem cell promote Tregs differentiation and prolong allograft survival.
Ou Q; Dou X; Tang J; Wu P; Pan D
Cell Tissue Res; 2022 Sep; 389(3):465-481. PubMed ID: 35688948
[TBL] [Abstract][Full Text] [Related]
28. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
[TBL] [Abstract][Full Text] [Related]
29. Endometriotic mesenchymal stem cells significantly promote fibrogenesis in ovarian endometrioma through the Wnt/β-catenin pathway by paracrine production of TGF-β1 and Wnt1.
Li J; Dai Y; Zhu H; Jiang Y; Zhang S
Hum Reprod; 2016 Jun; 31(6):1224-35. PubMed ID: 27005891
[TBL] [Abstract][Full Text] [Related]
30. Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment.
Gulley JL; Schlom J; Barcellos-Hoff MH; Wang XJ; Seoane J; Audhuy F; Lan Y; Dussault I; Moustakas A
Mol Oncol; 2022 Jun; 16(11):2117-2134. PubMed ID: 34854206
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer.
Funaki S; Shintani Y; Kawamura T; Kanzaki R; Minami M; Okumura M
Oncol Rep; 2017 Oct; 38(4):2277-2284. PubMed ID: 28849209
[TBL] [Abstract][Full Text] [Related]
32. Evidence that cervical cancer cells cultured as tumorspheres maintain high CD73 expression and increase their protumor characteristics through TGF-β production.
García-Rocha R; Monroy-García A; Carrera-Martínez M; Hernández-Montes J; Don-López CA; Weiss-Steider B; Monroy-Mora KA; Ponce-Chavero MLÁ; Montesinos-Montesinos JJ; Escobar-Sánchez ML; Castillo GM; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Mora-García ML
Cell Biochem Funct; 2022 Oct; 40(7):760-772. PubMed ID: 36070413
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-β-Expressing Mesenchymal Stem Cells Induce Local Tolerance in a Rat Liver Transplantation Model of Acute Rejection.
Tang J; Yang R; Lv L; Yao A; Pu L; Yin A; Li X; Yu Y; Nyberg SL; Wang X
Stem Cells; 2016 Nov; 34(11):2681-2692. PubMed ID: 27333806
[TBL] [Abstract][Full Text] [Related]
34. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
[TBL] [Abstract][Full Text] [Related]
35. Immune checkpoint molecules are regulated by transforming growth factor (TGF)-
Shrestha R; Bridle KR; Crawford DHG; Jayachandran A
Int J Med Sci; 2021; 18(12):2466-2479. PubMed ID: 34104078
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta.
Patel SA; Meyer JR; Greco SJ; Corcoran KE; Bryan M; Rameshwar P
J Immunol; 2010 May; 184(10):5885-94. PubMed ID: 20382885
[TBL] [Abstract][Full Text] [Related]
37. Stromal Cell PD-L1 Inhibits CD8
O'Malley G; Treacy O; Lynch K; Naicker SD; Leonard NA; Lohan P; Dunne PD; Ritter T; Egan LJ; Ryan AE
Cancer Immunol Res; 2018 Nov; 6(11):1426-1441. PubMed ID: 30228206
[TBL] [Abstract][Full Text] [Related]
38. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
[TBL] [Abstract][Full Text] [Related]
39. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway.
Yuan B; El Dana F; Ly S; Yan Y; Ruvolo V; Shpall EJ; Konopleva M; Andreeff M; Battula VL
PLoS One; 2020; 15(11):e0242809. PubMed ID: 33253299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
